Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis

Introduction: Ustekinumab (UST) has been approved for the treatment of moderate-to-severe ulcerative colitis (UC). Real-world data showing the effectiveness and safety of UST are necessary to confirm the results of clinical trials for applicability in daily clinical practice. Although some studies h...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Genta Uchida, Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Eri Ishikawa, Kazuhiro Furukawa, Tadashi Iida, Yasuyuki Mizutani, Kentaro Yamao, Takuya Ishikawa, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami, Hiroki Kawashima
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Karger Publishers 2023-06-01
coleção:	Inflammatory Intestinal Diseases
Assuntos:	real-world evidence ustekinumab ulcerative colitis effectiveness risk factor
Acesso em linha:	https://beta.karger.com/Article/FullText/531497
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!